Item 4 — Purpose of Transaction
The Reporting Persons hold the securities reported herein for investment purposes and in the capacities further described below. Dr. Bokhari acquired, and holds, such securities both directly, and through his control of RBx Capital, LP, as applicable, in connection with his service as Executive Chairman and Chief Executive Officer of the Issuer, and as an initial investor in the securities of the Issuer at the time of its reverse take-over transaction as described in the Issuer's filings with the Commission. In his capacity as Executive Chairman and Chief Executive Officer of the Issuer, Dr. Bokhari participates in the management and direction of the business and affairs of the Issuer and, in that capacity, regularly considers, formulates and discusses with other members of management and with the board of directors of the Issuer, and votes upon as a director, matters relating to the Issuer's business, operations, strategy, capitalization, financing arrangements, dividend policy, board and management composition, corporate structure and strategic alternatives, including matters of the types described in clauses (a) through (j) of Item 4 of Schedule 13D. Dr. Bokhari may take such actions in his capacity as an officer and director of the Issuer, in each case subject to his fiduciary duties to the Issuer and its shareholders. Each Reporting Person intends to review its investment in the Issuer on a continuing basis and, depending upon various factors, including the Issuer's business, financial position, strategy and prospects, the price levels of the common shares, general market, industry and economic conditions, applicable legal and regulatory requirements (including the Issuer's insider trading policy and applicable blackout periods) and other investment opportunities and considerations, may from time to time acquire additional common shares or other securities of the Issuer, or dispose of all or a portion of the securities that such Reporting Person now beneficially owns or may hereafter acquire, in the open market, in privately negotiated transactions, through the exercise of stock options or the vesting or settlement of other equity awards, in transactions with the Issuer, pursuant to a trading plan adopted in accordance with Rule 10b5-1 under the Act, or otherwise. Dr. Bokhari also expects to receive additional equity awards from the Issuer from time to time as compensation for his services as an officer and director of the Issuer. Except as set forth in this Item 4, the Reporting Persons do not currently have any plans or proposals that relate to or would result in any of the transactions or other matters specified in clauses (a) through (j) of Item 4 of Schedule 13D, although each Reporting Person reserves the right to formulate and pursue any such plans or proposals in the future, and to change its intentions with respect to any and all of the matters referred to in this Item 4.